In vivo antimalarial action of a lipophilic iron (III) chelator: Suppression of plasmodium vinckei infection by reversed siderophore

We assessed in vivo antimalarial action of a lipophilic iron (III) chelator belonging to a new synthetic family of biomimetic siderophores previously termed reversed siderophores (RSFs). The family member, RSF ileum2, was chosen for its high membrane permeability and fast irreversible inhibition of human malaria parasite growth in vitro. [Shanzer A, et al., Proc Natl Acad Sci USA 88:6585, 1991 and Lytton SD, et al., Blood 81:214, 1993]. The lipophilic drug was administered to Swiss mice by subcutaneous route in fractionated coconut oil at a dosage of 0.37 g/kg every 8 hr with no adverse reactions observed. After 3–4 injections demonstrable suppression of Plasmodium vinckei petteri infection was observed and an additional 3–4 injections resulted in 2–3‐fold lower parasitemia with prolonged survival time over sham‐injected control mice.

[1]  S. Lytton,et al.  The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. , 1993, The Journal of clinical investigation.

[2]  S. Lytton,et al.  Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity. , 1993, Blood.

[3]  S. Lytton,et al.  Monitoring of iron(III) removal from biological sources using a fluorescent siderophore. , 1992, Analytical biochemistry.

[4]  S. Lytton,et al.  Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal. , 1991, Molecular pharmacology.

[5]  S. Lytton,et al.  Reversed siderophores act as antimalarial agents. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Labie,et al.  Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria , 1991, American journal of hematology.

[7]  P. Dobbin,et al.  The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators. , 1991, Blood.

[8]  H. Ginsburg,et al.  Chronotherapy of malaria: an approach to malaria chemotherapy. , 1991, Parasitology today.

[9]  T. Peto,et al.  Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro. , 1990, Blood.

[10]  J. Hazell,et al.  Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage , 1989, British journal of haematology.

[11]  J. Porter.  Oral iron chelators: Prospects for future development , 1989, European journal of haematology.

[12]  R. Nicolosi,et al.  A non‐human primate model for the study of oral iron chelators , 1989, British journal of haematology.

[13]  L. Scheibel,et al.  Antimalarial activity of selected aromatic chelators V. Localization of 59Fe in Plasmodium falciparum in the presence of oxines. , 1989, Progress in clinical and biological research.

[14]  J. Libman,et al.  Synthetic ferrichrome analogues with growth promotion activity for Arthrobacter flavescens. , 1988, Biochemical and biophysical research communications.

[15]  D. Mazier,et al.  Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria. , 1988, The American journal of tropical medicine and hygiene.

[16]  J. Eaton,et al.  Antimalarial properties of orally active iron chelators , 1988 .

[17]  T. Peto,et al.  Deferoxamine inhibition of malaria is independent of host iron status , 1988, The Journal of experimental medicine.

[18]  D. Weatherall,et al.  Iron-chelating therapy. , 1988, Critical reviews in clinical laboratory sciences.

[19]  R. Rossan,et al.  Desferrioxamine Suppresses Plasmodium falciparum in Aotus Monkeys 1 , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  D. Spira,et al.  Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. , 1985, Experimental parasitology.

[21]  R. Nagel,et al.  Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. , 1982, The American journal of tropical medicine and hygiene.

[22]  J. Graziano,et al.  Rhodotorulic acid--investigation of its potential as an iron-chelating drug. , 1979, The Journal of pharmacology and experimental therapeutics.